# Nuvectis Pharma, Inc.: Form S-1/A, filed Jan 18, 2022

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: S-1/A
- Filed: 2022-01-18
- Accepted by EDGAR: Jan 14, 2022, 18:40 ET
- Period: not reported
- Accession: 0001104659-22-004520
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465922004520/tm2134024-7_s1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465922004520/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465922004520/tm2134024-7_s1a.htm

Filed Jan 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-004520. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.
